The Last Act

By Richard Gallagher The Last Act My final editorial. Ten problems I believe could bollix biology in years to come. After seven-and-a-half years as editor, and with 130-plus editorials behind me, I’m facing the tyranny of the blank page for the final time: my last editorial. How lucky I’ve been to be editor of this publication at this time. I often think of the poor editor of a glossy golf magazine who talked at a publishing me

Written byRichard Gallagher
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

After seven-and-a-half years as editor, and with 130-plus editorials behind me, I’m facing the tyranny of the blank page for the final time: my last editorial.

How lucky I’ve been to be editor of this publication at this time. I often think of the poor editor of a glossy golf magazine who talked at a publishing meeting a couple of years ago. His comments went something like this: “We have three types of content: Where to play golf, what to play golf with, and how to play golf. Of these, the third is of far the most interest to readers, but the advice has been essentially unchanged since the magazine started in 1959. We are in a constant search for new ways to say the same thing”.

Nice Shot

Should Evolutionary Theory Evolve?

Mind Your Manners

Our quandary at The Scientist is the opposite: With so much going on in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies